VYNE Therapeutics Inc. (VYNE) › Cost of RevenueVYNE Therapeutics Inc. (VYNE) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2018: $02019: $02020: $1.39M2021: $3.35M$3.35M2018Cost of Revenue (USD)2021Fiscal YearCost of RevenueChange YoY2021$3.35M+140.5%2020$1.39M—2019$0—2018$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share